Skip to content

Celcuity CELC Convertible Preferred Stock Issued Shares

Convertible Preferred Stock Issued Shares at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
0
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Exelixis logo
ExelixisEXEL
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Celcuity's convertible preferred stock issued shares?
Celcuity (CELC) reported convertible preferred stock issued shares of 0 in Q1 2026.
How has Celcuity's convertible preferred stock issued shares changed year-over-year?
Celcuity's convertible preferred stock issued shares decreased by 100.0% year-over-year, from 317.6K to 0.
What does convertible preferred stock issued shares mean?
Number of convertible preferred shares that have been issued, whether held by investors or in treasury.